Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | USP17L3 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | SNX4 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | SHROOM2 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | SMC4 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | BMP4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | RGR | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | RBMS3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | OSR1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | ARAP2 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | SMCO4 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |